David Trueman
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
Health-economic challenges for new Alzheimer's disease treatments.
Journal: The journal of prevention of Alzheimer's disease
Published: February 19, 2026
Estimating the long-term health outcomes of treatment with lecanemab in early Alzheimer's disease: a modelling study.
Journal: Journal of medical economics
Published: January 28, 2026
Estimated Long-Term Durability of Valoctocogene Roxaparvovec Treatment in Male patients with Severe Hemophilia A: An Extrapolation of Clinical Data.
Journal: Advances in therapy
Published: June 18, 2025
An Indirect Treatment Comparison of Lenvatinib for the First-Line Treatment of Patients with Unresectable Hepatocellular Carcinoma.
Journal: Advances in therapy
Published: September 19, 2024
The cost-effectiveness of brigatinib in adult patients with ALK inhibitor-naive ALK-positive non-small cell lung cancer from a US perspective.
Journal: Journal of managed care & specialty pharmacy
Published: August 24, 2022
Brentuximab Vedotin Plus CHP in Frontline sALCL: Adjusted Estimates of Efficacy and Cost-Effectiveness Removing the Effects of Re-Treatment with Brentuximab Vedotin.
Journal: PharmacoEconomics - open
Published: June 14, 2022
Cost Effectiveness of Inclisiran in Atherosclerotic Cardiovascular Patients with Elevated Low-Density Lipoprotein Cholesterol Despite Statin Use: A Threshold Analysis.
Journal: American journal of cardiovascular drugs : drugs, devices, and other interventions
Published: March 13, 2022
The Cost-Effectiveness of Lenvatinib in the Treatment of Advanced or Unresectable Hepatocellular Carcinoma from a Canadian Perspective.
Journal: Canadian journal of gastroenterology & hepatology
Published: May 29, 2020
The clinical and cost-effectiveness of supplemental parenteral nutrition in oncology.
Journal: ESMO open
Published: February 12, 2020
An Economic Evaluation of Voretigene Neparvovec for the Treatment of Biallelic RPE65-Mediated Inherited Retinal Dystrophies in the UK.
Journal: Advances in therapy
Published: December 12, 2019
RE: Cost-effectiveness of sacubitril/valsartan versus enalapril in patients with heart failure and reduced ejection fraction.
Journal: Journal of medical economics
Published: July 24, 2018
Cost-effectiveness of sacubitril/valsartan in chronic heart-failure patients with reduced ejection fraction.
Journal: Swiss medical weekly
Published: November 30, 2017
Last Updated: 09/26/2026